NICOLAS PERTILE: Open Payments
NPI 1538750153 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,209 in 98 payments from 19 companies in 2025. Trend: 2023 $1,232 · 2024 $1,861 · 2025 $2,209
Food & beverage: $2,209
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $522 |
| AstraZeneca Pharmaceuticals LP | 16 | $509 |
| GlaxoSmithKline, LLC. | 12 | $211 |
| Amgen Inc. | 9 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $138 |
| Lilly USA, LLC | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Almatica Pharma LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $52 |
Products named: FARXIGA, Wegovy, TRELEGY ELLIPTA, AIRSUPRA, CAPLYTA, JARDIANCE, EVENITY, MOUNJARO.
Industry payments across PA — which companies pay providers there.
